Nagasawa T

No ORCID on file · 4 papers in corpus · active 2007-2026

Study types

  • other 1

Condition tags

  • endometriosis 1
2026
Title: AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 study.
Cancer immunology, immunotherapy : CII ·doi:10.1007/s00262-026-04324-z

Transcriptomic classification methods have been proposed for ovarian clear cell carcinoma. However, their clinical significance and association with pathologically evaluated tumor-infiltrating lymphocytes (TILs) remain unclear. We establish…

other 2023
Suppression of hypothalamic-pituitary-gonadal function by linzagolix in benign prostatic hyperplasia and polycystic ovary syndrome animal models
Clinical and experimental pharmacology & physiology ·doi:10.1111/1440-1681.13817

The hypothalamic-pituitary-gonadal (HPG) axis is an important regulatory mechanism involved primarily in the development and regulation of the reproductive systems. The suppression of the HPG axis by gonadotropin-releasing hormone (GnRH) an…

2021
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas.
Cancers ·doi:10.3390/cancers13236120

Ovarian cancer has the worst prognosis among gynecological cancers. In particular, clear cell and mucinous carcinomas are less sensitive to chemotherapy. The establishment of new therapies is necessary to improve the treatment outcomes for …

2007
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer.
British journal of cancer ·doi:10.1038/sj.bjc.6603552

Ovarian cancer, and clear cell carcinoma in particular, reportedly increases the risk of venous thromboembolism (VTE). However, the mechanisms remain unclear. Tissue factor (TF) supposedly represents a major factor in the procoagulant activ…